Trial intelligence / Profile preview

Perineural Injection Therapy vs Steroid for Carpal Tunnel Syndrome

NCT02990962Completed

Sponsor
Tri-Service General Hospital
Start
Dec 2016
Primary completion
Apr 2018
Countries
1
01

Overview

Randomised, double-blind trial of dextrose in carpal tunnel syndrome (CTS) (2 arms), sponsored by Tri-Service General Hospital. Primary endpoint: Visual Analog Scale at 6 months. Started Dec 2016; status: completed.

02

Drugs

dextrose
03

Conditions

carpal tunnel syndrome (CTS)

Beyond the preview

Go deeper on NCT02990962.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02990962.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call